by GV Team | Mar 17, 2021 | Coronavirus, GrandView News, Messages from CEO, Patient Safety, Vaccinations
Blog by Mark Prifogle, GrandView Pharmacy CEO Together, we have been changing lives. One shot at a time. While many of us were not in the field first hand, all of those who served behind the scenes, offered support or worked in the pharmacy had a helping hand to...
by GV Team | Apr 16, 2020 | Coronavirus, Drug Information, Messages from CEO, Patient Safety, Resources
Article by TRC, Pharmacists Letter Posted April 3, 2020: Article in Progress. We’re releasing this article ahead of our May 2020 issue to quickly provide information to our readers. The information contained in this version is based on the best evidence available to...
by GV Team | Mar 11, 2020 | Coronavirus, GrandView News, Messages from CEO, Patient Safety, Resources
Blog by Mark Prifogle, GrandView Pharmacy CEO March 11, 2020 GrandView Pharmacy Team Members, Residents and Community Leaders, We continue to follow the rapid developments surrounding the COVID-19 virus and want to update you on current and upcoming efforts to protect...
by GV Team | Jan 20, 2020 | Drug Information, Messages from CEO, Patient Safety, Resources
Article by American Family Physician, www.aafp.org The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (i.e., at least 65 years of age), originally developed by Mark H. Beers in 1991, continue to be used by the American Geriatrics Society...
by GV Team | Nov 12, 2019 | Drug Information, Messages from CEO, Patient Safety, Resources
Blog by Mark Prifogle, GrandView Pharmacy CEO You may have noticed a new sticker on prescription packaging that states “NIOSH” or hazardous drugs recently. This sticker indicates a revised class of drugs around hazardous waste/medications update from earlier...
by GV Team | Jul 19, 2019 | Drug Information, Messages from CEO, Patient Safety, Resources
Update from the Centers for Disease Control and Prevention Tuberculin Skin Test – Aplisol Shortage The Centers for Disease Control and Prevention (CDC) is expecting a 3–10 month nationwide shortage of Aplisol. Aplisol is one of two purified-protein derivative (PPD)...
